LULU 3Q25 First Take: overall a beat against a low bar. Overall, the quarter came in better than muted expectations.After two straight guide-downs, Q3 results topped the high end of guidance with revenue of RMB 2.57bn (+7.1% YoY; guide 3%-4%). Execution was stronger than the company had telegraphed.On that basis, the company raised full-year revenue guidance. It moved from 2%-4% to 4%-6%.1) Revenue: by category, core womenswear delivered RMB 1.65bn, up 5.7% YoY, slightly ahead of market expectations. However, growth continued to decelerate QoQ.Dolphin Research believes that after organizational changes early this year, tighter design–merch coordination restored the product launch cadence to its historical norm. Newness contributed above expectations.Menswear posted RMB 600mn, up 8.1% YoY. The trend ticked up slightly vs. the prior two quarters.By region, North America, the home market, remained soft, down 1.5% YoY. AOV, conversion, and store traffic all continued to decline.China was the standout at +43% YoY, the fastest pace in a year. Dolphin Research attributes the strength mainly to livestreaming on e-comm platforms.2) GPM: tariffs and the removal of the de minimis exemption (effective Aug) drove a notable increase in supply chain costs. GPM fell 290bps YoY to 55.6%.On opex, international expansion led to more hiring and higher compensation in overseas ops, nudging the opex ratio up 50bps. Core OPM was 17.1%, down 340bps. $Lululemon(LULU.US)

U.S. Stock Movement Update: Agape ATP surges 87%, Oriental Culture plummets 79%, multiple stocks show significant movement

Market Overview of US Stocks in the Last Hour The US stock market has shown a significant sector rotation in the past hour, with technology and pharmaceutical stocks performing particularly well. Small-cap stocks and thematic stocks have experienced large fluctuations, with noticeable capital inflows. Market sentiment is relatively active, with short-term enthusiasm rising, and some individual stocks have shown significant price movements. The stock with the largest abnormal movement in the last hour is Agape ATP, which surged 87.35%, with trading volume significantly increasing and short-term capital inflows evident, leading to heightened market sentiment. Strong stocks include: 1. SMX Security Matters: up 67.70%, with a 10-day increase of 1113.76%, driven significantly by short-term capital. 2. Grande: up 59.08%, with a 5-day increase of 58.77%, gaining market attention. 3. HeartBeam: up 52.91%, with a 6-month increase of 51.28%, showing clear capital inflows. 4. Velo3D: up 38.26%, with increased trading volume and active short-term capital. 5. Mawson Infrastructure: up 37.54%, with increased trading volume and positive market sentiment. 6. Treasure Gbl: up 26.62%, with increased trading volume driven by short-term capital. 7. CapsoVision: up 25.59%, with increased trading volume and heightened market attention. 8. Nextdoor: up 25.34%, reaching a new 60-day high, with noticeable capital inflows

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks rose, with NYSE Health Care Index up 1% and XLV ETF up 0.8%. Pfizer plans to cut 200 jobs in Switzerland, shares up 0.8%. HeartBeam shares surged 60% after FDA clearance for ECG software. Centessa Pharmaceuticals aims to redefine narcolepsy treatment, shares rose 2.4% after Oppenheimer raised price target to $62. MT Newswires does not provide investment advice.

Roth MKM Reaffirms Their Buy Rating on HeartBeam (BEAT)

Roth MKM analyst Kyle Bauser reiterated a Buy rating on HeartBeam with a price target of $4.00. Bauser covers the Healthcare sector and has an average return of -11.9% with a 38.03% success rate. The analyst consensus for HeartBeam is a Strong Buy with a $4.83 average price target.

Heartbeam shares are trading higher after the company announced it received FDA clearance for its 12-lead electrocardiogram synthesis software for the assessment of arrhythmias.